105 related articles for article (PubMed ID: 8709104)
1. Novel cyclic analogs of angiotensin II with cyclization between positions 5 and 7: conformational and biological implications.
Zhang WJ; Nikiforovich GV; Pérodin J; Richard DE; Escher E; Marshall GR
J Med Chem; 1996 Jul; 39(14):2738-44. PubMed ID: 8709104
[TBL] [Abstract][Full Text] [Related]
2. Three-dimensional recognition requirements for angiotensin agonists: a novel solution for an old problem.
Nikiforovich GV; Marshall GR
Biochem Biophys Res Commun; 1993 Aug; 195(1):222-8. PubMed ID: 8363604
[TBL] [Abstract][Full Text] [Related]
3. Conformational analysis of two cyclic analogs of angiotensin: implications for the biologically active conformation.
Nikiforovich GV; Kao JL; Plucinska K; Zhang WJ; Marshall GR
Biochemistry; 1994 Mar; 33(12):3591-8. PubMed ID: 8142357
[TBL] [Abstract][Full Text] [Related]
4. Structural features of angiotensin II which are important for biologic activity.
Peach MJ
Kidney Int Suppl; 1979 Mar; (9):S3-6. PubMed ID: 289861
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and AT2 receptor-binding properties of angiotensin II analogues.
Rosenström U; Sköld C; Lindeberg G; Botros M; Nyberg F; Hallberg A; Karlén A
J Pept Res; 2004 Nov; 64(5):194-201. PubMed ID: 15485557
[TBL] [Abstract][Full Text] [Related]
6. On the structural basis of the hypertensive properties of angiotensin II: a solved mystery or a controversial issue?
Tzakos AG; Gerothanassis IP; Troganis AN
Curr Top Med Chem; 2004; 4(4):431-44. PubMed ID: 14965310
[TBL] [Abstract][Full Text] [Related]
7. The design and synthesis of a potent Angiotensin II cyclic analogue confirms the ring cluster receptor conformation of the hormone Angiotensin II.
Matsoukas JM; Polevaya L; Ancans J; Mavromoustakos T; Kolocouris A; Roumelioti P; Vlahakos DV; Yamdagni R; Wu Q; Moore GJ
Bioorg Med Chem; 2000 Jan; 8(1):1-10. PubMed ID: 10968258
[TBL] [Abstract][Full Text] [Related]
8. An effort to understand the molecular basis of hypertension through the study of conformational analysis of losartan and sarmesin using a combination of nuclear magnetic resonance spectroscopy and theoretical calculations.
Mavromoustakos T; Kolocouris A; Zervou M; Roumelioti P; Matsoukas J; Weisemann R
J Med Chem; 1999 May; 42(10):1714-22. PubMed ID: 10346924
[TBL] [Abstract][Full Text] [Related]
9. On the molecular basis of the recognition of angiotensin II (AII). NMR structure of AII in solution compared with the X-ray structure of AII bound to the mAb Fab131.
Tzakos AG; Bonvin AM; Troganis A; Cordopatis P; Amzel ML; Gerothanassis IP; van Nuland NA
Eur J Biochem; 2003 Mar; 270(5):849-60. PubMed ID: 12603318
[TBL] [Abstract][Full Text] [Related]
10. Proposals for the angiotensin II receptor-bound conformation by comparative computer modeling of AII and cyclic analogs.
Joseph MP; Maigret B; Scheraga HA
Int J Pept Protein Res; 1995 Dec; 46(6):514-26. PubMed ID: 8748712
[TBL] [Abstract][Full Text] [Related]
11. Synthesis of two new angiotensin II analogs.
Paruszewski R; Matusiak R; Janiec W; Folwarczna J; Sliwiński L; Pytlik M
Pol J Pharmacol Pharm; 1990; 42(5):479-82. PubMed ID: 2098755
[TBL] [Abstract][Full Text] [Related]
12. Effects of D-amino acid substitution on antagonist activities of angiotensin II analogues.
Samanen J; Narindray D; Adams W; Cash T; Yellin T; Regoli D
J Med Chem; 1988 Mar; 31(3):510-6. PubMed ID: 3346871
[TBL] [Abstract][Full Text] [Related]
13. The active state of the AT1 angiotensin receptor is generated by angiotensin II induction.
Noda K; Feng YH; Liu XP; Saad Y; Husain A; Karnik SS
Biochemistry; 1996 Dec; 35(51):16435-42. PubMed ID: 8987975
[TBL] [Abstract][Full Text] [Related]
14. Bicyclic tripeptide mimetics with reverse turn inducing properties.
Johannesson P; Lindeberg G; Tong W; Gogoll A; Karlén A; Hallberg A
J Med Chem; 1999 Feb; 42(4):601-8. PubMed ID: 10052967
[TBL] [Abstract][Full Text] [Related]
15. Conformational restriction of angiotensin II: cyclic analogues having high potency.
Spear KL; Brown MS; Reinhard EJ; McMahon EG; Olins GM; Palomo MA; Patton DR
J Med Chem; 1990 Jul; 33(7):1935-40. PubMed ID: 2362273
[TBL] [Abstract][Full Text] [Related]
16. In vitro degradation of angiotensin II (A-II) by human placental subcellular fractions, pregnancy sera and purified placental aminopeptidases.
Mizutani S; Akiyama H; Kurauchi O; Taira H; Narita O; Tomoda Y
Acta Endocrinol (Copenh); 1985 Sep; 110(1):135-9. PubMed ID: 3898693
[TBL] [Abstract][Full Text] [Related]
17. An investigation of angiotensin II agonist and antagonist analogues with 5,5-dimethylthiazolidine-4-carboxylic acid and other constrained amino acids.
Samanen J; Cash T; Narindray D; Brandeis E; Adams W; Weideman H; Yellin T; Regoli D
J Med Chem; 1991 Oct; 34(10):3036-43. PubMed ID: 1920354
[TBL] [Abstract][Full Text] [Related]
18. Photoaffinity labeling of the angiotensin II receptor. 3. Receptor inactivation with photolabile hormone analogues.
Escher EH; Guillemette G
J Med Chem; 1979 Sep; 22(9):1047-50. PubMed ID: 226704
[TBL] [Abstract][Full Text] [Related]
19. Multiple binding modes for the receptor-bound conformations of cyclic AII agonists.
Plucinska K; Kataoka T; Yodo M; Cody WL; He JX; Humblet C; Lu GH; Lunney E; Major TC; Panek RL
J Med Chem; 1993 Jun; 36(13):1902-13. PubMed ID: 8515427
[TBL] [Abstract][Full Text] [Related]
20. Design, synthesis, and biological activities of four angiotensin II receptor ligands with gamma-turn mimetics replacing amino acid residues 3-5.
Schmidt B; Lindman S; Tong W; Lindeberg G; Gogoll A; Lai Z; Thörnwall M; Synnergren B; Nilsson A; Welch CJ; Sohtell M; Westerlund C; Nyberg F; Karlén A; Hallberg A
J Med Chem; 1997 Mar; 40(6):903-19. PubMed ID: 9083479
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]